- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06598397
Använda Multiphase Optimization Strategy (MOST) för att optimera ett kostnadseffektivt, hållbart och skalbart paket för rökavvänjning för rökare i klinisk hiv-vård
This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
This study will utilize Multiphase Optimization Strategy (MOST) to optimize a smoking cessation treatment for HIV clinical care by directly targeting patient barriers to quitting and clinical care barriers to reaching and effectively treating a broad heterogeneous population of smokers living with HIV. The four intervention components will be aimed at barriers to quitting among smokers living with HIV and include Motivational Interviewing; Peer Mentoring; Text-messaging; Combination Nicotine Replacement Therapy. These components have shown promise in research but are under-utilized to help smokers living with HIV quit and have not been tested in an optimization trial. This study will also incorporate data to evaluate the fidelity, acceptability and feasibility of the interventions in the HIV clinical care context in order to identify the most cost-effective, sustainable and scalable tobacco treatment package for the care environment.
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 4
Kontakter och platser
Studiekontakt
- Namn: Jennifer Cantrell, DrPH, MPA
- Telefonnummer: 212-998-5797
- E-post: jennifer.cantrell@nyu.edu
Studieorter
-
-
New York
-
New York, New York, Förenta staterna, 10003
- Rekrytering
- New York University School of Global Public Health
-
Kontakt:
- Jennifer Cantrell, DrPH, MPA
- Telefonnummer: 212-998-5797
- E-post: jennifer.cantrell@nyu.edu
-
Kontakt:
- Rachel Warshaw, MPH
- Telefonnummer: 23948 212-992-3948
- E-post: rw1738@nyu.edu
-
Huvudutredare:
- Jennifer Cantrell, DrPH, MPA
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Status as HIV+
- Age 18 or older
- Currently smokes ≥ 5 CPD, on average, in past month
- Positive for salivary cotinine
- Able to understand the nature of the study and the consenting process
- Is engaged in HIV clinical care
- Living in larger NYC metropolitan area currently and for the next 6-8 months
Exclusion Criteria:
- Suffers from any medical condition or contraindication precluding use of nicotine replacement therapy
- Current use of any tobacco cessation medications (varenicline, NRT patch, nicotine gum, lozenge, spray or inhaler, or bupropion)
- Currently participating in a smoking cessation program
- Pregnant or nursing and plans to be in next 6 months
- Has schizophrenia/schizo-affective disorder
- Does not have a functioning mobile phone that can receive text messages
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Faktoriell uppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Condition 1
Participants will receive the Core Component. |
|
|
Experimentell: Condition 2
Participants will receive the Core Component and Combination-NRT intervention. |
If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day. |
|
Experimentell: Condition 3
Participants will receive the Core Component and Text Messaging intervention. |
NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov. |
|
Experimentell: Condition 4
Participants will receive the Core Component as well as the Combination-NRT and Text Messaging interventions. |
If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day. NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov. |
|
Experimentell: Condition 5
Participants will receive the Core Component and Peer Mentoring intervention. |
Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience. |
|
Experimentell: Condition 6
Participants will receive the Core Component as well as the Combination-NRT and Peer Mentoring interventions. |
If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day. Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience. |
|
Experimentell: Condition 7
Participants will receive the Core Component as well as the Text Messaging and Peer Mentoring interventions. |
NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov. Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience. |
|
Experimentell: Condition 8
Participants will receive the Core Component as well as the Combination-NRT, Text Messaging and Peer Mentoring interventions. |
If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day. NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov. Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience. |
|
Experimentell: Condition 9
Participants will receive the Core Component and Motivational Interviewing Counseling intervention. |
Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment. |
|
Experimentell: Condition 10
Participants will receive the Core Component as well as the Combination-NRT and Motivational Interview Counseling interventions. |
If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day. Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment. |
|
Experimentell: Condition 11
Participants will receive the Core Component as well as the Text Messaging and Motivational Interview Counseling interventions. |
NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov. Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment. |
|
Experimentell: Condition 12
Participants will receive the Core Component as well as the Combination-NRT, Text Messaging and Motivational Interview Counseling interventions. |
If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day. NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov. Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment. |
|
Experimentell: Condition 13
Participants will receive the Core Component as well as the Peer Mentoring and Motivational Interview Counseling interventions. |
Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience. Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment. |
|
Experimentell: Condition 14
Participants will receive the Core Component as well as the Combination-NRT, Peer Mentoring and Motivational Interview Counseling interventions. |
If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day. Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience. Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment. |
|
Experimentell: Condition 15
Participants will receive the Core Component as well as the Text Messaging, Peer Mentoring and Motivational Interview Counseling interventions. |
NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov. Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience. Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment. |
|
Experimentell: Condition 16
Participants will receive the Core Component as well as the Combination-NRT, Text Messaging, Peer Mentoring, and Motivational Interview Counseling interventions. |
If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day. NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov. Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience. Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Biochemically-validated 7-day point prevalence smoking abstinence among SLWH in HIV clinical care
Tidsram: 32 weeks
|
Self-reported 7-day cigarette PPA (point prevalence abstinence), with biochemical verification of CO (carbon monoxide) ≤6 ppm and negative salivary cotinine |
32 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Self-reported 30-day PPA
Tidsram: 32 weeks
|
Self-reported 30-day cigarette PPA (point prevalence abstinence) |
32 weeks
|
|
Self-reported 7-day PPA
Tidsram: 8 and 16 weeks
|
Self-reported 7-day cigarette PPA (point prevalence abstinence) with carbon monoxide verification (<=6 ppm) |
8 and 16 weeks
|
|
Self-reported 30-day PPA
Tidsram: 8 and 16 weeks
|
Self-reported 30-day cigarette PPA (point prevalence abstinence) |
8 and 16 weeks
|
|
Quit attempts
Tidsram: 8, 16, and 32 weeks
|
Number of quit attempts (of at least 24 hours) in last 7 days and since last assessment |
8, 16, and 32 weeks
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Blodburna infektioner
- Urogenitala sjukdomar
- Genitala sjukdomar
- Immunsystemets sjukdomar
- Infektioner
- RNA-virusinfektioner
- Virussjukdomar
- Smittsamma sjukdomar
- Sexuellt överförbara sjukdomar, virala
- Sexuellt överförbara sjukdomar
- Lentivirusinfektioner
- Retroviridae-infektioner
- Immunologiska bristsyndrom
- Långsamma virussjukdomar
- HIV-infektioner
- Beteende
- Hälsobeteende
- Förvärvat immunbristsyndrom
- Rökavvänjning
- Vårdtjänster
- Sjukvårdsanläggningar och tjänster
- Gemenskapens hälsovård
- Beteendediscipliner och aktiviteter
- Direktivrådgivning
- Mentalvårdstjänster
- Motiverande intervjuer
- Rådgivning
Andra studie-ID-nummer
- CA268932
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .